✦ LIBER ✦

CV8 PHARMACOECONOMIC CONSEQUENCES OF PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE CZECH REPUBLIC

✍ Scribed by L Praznovcova; L Strnad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CV5 PHARMACOECONOMIC EVALUATION OF SIMVA

✍ A Plich; KJ Filipiak; J Splawinski; W Gumulka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Management of Cardiometabolic Syndrome i

✍ M. Dominique Ashen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 950 KB

Cost-Effectiveness Analysis of Atorvasta

✍ Klimes, J.; Vocelka, M.; Dolezal, T.; Kruntoradova, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

CV1 A HEALTH ECONOMIC EVALUATION OF ASPI

✍ M Lamotte; L Annemans; T Evers; M Kubin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Combination niacin and statin therapy in

✍ Dr. Deborah R. Levy; Thomas A. Pearson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Primary and Secondary Prevention of Card

✍ Kriekard, Peter; Gharacholou, S. Michael; Peterson, Eric D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 220 KB